Course Summary

Expiration Date: 04/14/2028

Psychedelic microdosing has become more popular for the treatment of mood disorders and traumatic experiences to support a more peaceful state and healing. Advocates and enthusiasts of psychedelic drug use in combination with therapy posit that microdosing is effective, although the evidence for safety and risk continues to be studied. Psychedelic drugs have different structures, but their mechanisms of action are typically similar. Psychedelic drug use differs between individuals, although cognitive and perceptual effects are generally experienced. The classic psychedelics include dimethyltryptamine (DMT), lysergic acid diethylamide (LSD), mescaline, and peyote, which can cause vivid hallucinations. LSD and psilocybin are the most common drugs used for microdosing, but other psychedelics and non-psychedelic drugs can also be microdosed.

Course Format

Homestudy

Course Syllabus

  • Introduction
  • Microdosing of Psychedelic Drug Types
  • The Psychedelic Experience
  • Microdosing Regimens
  • Microdosing Within Population Groups
    • Drugs Used for Microdosing
  • Microdosing Effectiveness: Personal Experiences
    • Cognition, Creativity, Functioning, Performance, and Well-Being
    • Anxiety and Depression
  • Microdosing Effectiveness Versus Placebo
    • Expectancy and Microdosing
    • Placebo and Microdosing
  • Microdosing Risk of Adverse Effects and Safety
  • Adverse Effects – Cardiac
  • Psychotherapy and Mystical Experiences Involving Microdosing
  • Case Study: Combining Hallucinogen Use and Prescription Drugs
    • Discussion: Risks of Mixing Psilocybin and Psychotropics
  • Summary

Author

Dana Bartlett, RN, BSN, MSN, MA, CSPI

Dana Bartlett is a professional nurse and author. His clinical experience includes 16 years of ICU and ER experience and over 27 years as a poison control center information specialist. Dana has published numerous CE and journal articles, written NCLEX material, textbook chapters, and more than 100 online CE articles, and done editing and reviewing for publishers such as Elsevier, Lippincott, and Thieme. He has written widely on the subject of toxicology and was a contributing editor, toxicology section, for Critical Care Nurse journal. He is currently employed at the Connecticut Poison Control Center. He lives in Wappingers Falls, NY.